These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12514939)
21. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025 [TBL] [Abstract][Full Text] [Related]
22. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Borlaug BA; Melenovsky V; Russell SD; Kessler K; Pacak K; Becker LC; Kass DA Circulation; 2006 Nov; 114(20):2138-47. PubMed ID: 17088459 [TBL] [Abstract][Full Text] [Related]
23. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. de Simone G; Wachtell K; Palmieri V; Hille DA; Beevers G; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Julius S; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Devereux RB Circulation; 2005 Apr; 111(15):1924-31. PubMed ID: 15837945 [TBL] [Abstract][Full Text] [Related]
24. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766 [TBL] [Abstract][Full Text] [Related]
25. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction. Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S; Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497 [TBL] [Abstract][Full Text] [Related]
26. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA; Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009 [TBL] [Abstract][Full Text] [Related]
28. The importance of methodology: how should we define left ventricular hypertrophy? Gondoni LA Am J Cardiol; 2009 Feb; 103(4):574. PubMed ID: 19195524 [No Abstract] [Full Text] [Related]
29. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331 [TBL] [Abstract][Full Text] [Related]
30. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
31. Impact of obesity on the risk of heart failure and its prognosis. Artham SM; Lavie CJ; Patel HM; Ventura HO J Cardiometab Syndr; 2008; 3(3):155-61. PubMed ID: 18983332 [TBL] [Abstract][Full Text] [Related]
32. Obesity and target organ damage: the heart. Schunkert H Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S15-20. PubMed ID: 12457294 [TBL] [Abstract][Full Text] [Related]
33. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. de Simone G; Gottdiener JS; Chinali M; Maurer MS Eur Heart J; 2008 Mar; 29(6):741-7. PubMed ID: 18204091 [TBL] [Abstract][Full Text] [Related]
34. Impact of left ventricular hypertrophy late after aortic valve replacement for aortic stenosis on cardiovascular morbidity and mortality. Zybach-Benz RE; Aeschbacher BC; Schwerzmann M Int J Cardiol; 2006 Apr; 109(1):41-7. PubMed ID: 15996776 [TBL] [Abstract][Full Text] [Related]
35. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Paoletti E; Specchia C; Di Maio G; Bellino D; Damasio B; Cassottana P; Cannella G Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888 [TBL] [Abstract][Full Text] [Related]
36. Sudden cardiac death and obesity. Plourde B; Sarrazin JF; Nault I; Poirier P Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1099-110. PubMed ID: 25160995 [TBL] [Abstract][Full Text] [Related]
37. Coronary artery disease and prevention of heart failure. Klein L; Gheorghiade M Med Clin North Am; 2004 Sep; 88(5):1209-35. PubMed ID: 15331314 [TBL] [Abstract][Full Text] [Related]
38. Cardiac function in massively obese patients and the effect of weight loss. Herrera MF; Deitel M Can J Surg; 1991 Oct; 34(5):431-4. PubMed ID: 1913384 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832 [TBL] [Abstract][Full Text] [Related]
40. The enigma of sudden cardiac death related to dieting. Surawicz B; Waller BF Can J Cardiol; 1995 Mar; 11(3):228-31. PubMed ID: 7889441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]